Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.

    Sadelain MW, Qin HY, Lauzon J, Singh B.

    Diabetes. 1990 May;39(5):583-9.PMID: 2139617 [PubMed - indexed for MEDLINE]Related articles

    2.

    Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.

    Qin HY, Sadelain MW, Hitchon C, Lauzon J, Singh B.

    J Immunol. 1993 Mar 1;150(5):2072-80.PMID: 8436836 [PubMed - indexed for MEDLINE]Related articles

    3.

    Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.

    Qu P, Ji RC, Shimoda H, Miura M, Kato S.

    Anat Rec A Discov Mol Cell Evol Biol. 2004 Dec;281(2):1326-36.PMID: 15386276 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice.

    McInerney MF, Pek SB, Thomas DW.

    Diabetes. 1991 Jun;40(6):715-25.PMID: 2040388 [PubMed - indexed for MEDLINE]Related articles

    5.

    Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.

    Qin HY, Elliott JF, Lakey JR, Rajotte RV, Singh B.

    J Autoimmun. 1998 Dec;11(6):591-601.PMID: 9878081 [PubMed - indexed for MEDLINE]Related articles

    6.

    Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells.

    Lee IF, Qin H, Trudeau J, Dutz J, Tan R.

    J Immunol. 2004 Jan 15;172(2):937-42.PMID: 14707066 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.

    Serreze DV, Chapman HD, Post CM, Johnson EA, Suarez-Pinzon WL, Rabinovitch A.

    J Immunol. 2001 Jan 15;166(2):1352-9.PMID: 11145720 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    [Complete Freund's adjuvant-induced splenic T cell apoptosis in the prevention of diabetes in non-obese diabetic mice]

    Wang XX, Niu XH, Zhou ZG.

    Hunan Yi Ke Da Xue Xue Bao. 2002 Apr 28;27(2):105-7. Chinese. PMID: 12575330 [PubMed - indexed for MEDLINE]Related articles

    9.

    Mechanisms of complete Freund's adjuvant protection against diabetes in BB rats: induction of non-specific suppressor cells.

    Qin HY, Suarez WL, Parfrey N, Power RF, Rabinovitch A.

    Autoimmunity. 1992;12(3):193-9.PMID: 1343767 [PubMed - indexed for MEDLINE]Related articles

    10.

    Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes.

    Lee IF, Qin H, Priatel JJ, Tan R.

    Eur J Immunol. 2008 Jan;38(1):82-9.PMID: 18085661 [PubMed - indexed for MEDLINE]Related articles

    11.

    [The effects of complete Freund's adjuvant on prevention of pancrentitis and diabetes mellitus in non-obese diabetic mice]

    Niu X, Zhou Z, Jiang T, Su H.

    Zhonghua Nei Ke Za Zhi. 2002 Apr;41(4):229-32. Chinese. PMID: 12133432 [PubMed - indexed for MEDLINE]Related articles

    12.

    The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse.

    Sobel DO, Yankelevich B, Goyal D, Nelson D, Mazumder A.

    Diabetes. 1998 Feb;47(2):186-91.PMID: 9519711 [PubMed - indexed for MEDLINE]Related articles

    13.

    Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.

    Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Miki M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M.

    J Immunol. 1996 Oct 15;157(8):3737-43.PMID: 8871677 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides.

    Vaysburd M, Lock C, McDevitt H.

    J Exp Med. 1995 Sep 1;182(3):897-902.PMID: 7650494 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.

    Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL.

    J Immunol. 2001 Jul 15;167(2):1081-9.PMID: 11441119 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.

    Gregori S, Giarratana N, Smiroldo S, Adorini L.

    J Immunol. 2003 Oct 15;171(8):4040-7.PMID: 14530324 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).

    Daniel D, Wegmann DR.

    Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):956-60.PMID: 8570667 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Regulation of autoimmune diabetes: characteristics of non-islet-antigen specific therapies.

    Gazda LS, Baxter AG, Lafferty KJ.

    Immunol Cell Biol. 1996 Oct;74(5):401-7.PMID: 8912002 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination